We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

65 hedge funds and large institutions have $72.3M invested in Immune Design Corp. in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

51.76% more ownership

Funds ownership: 0% → 51.76% (+52%)

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

50% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 16

8% more funds holding

Funds holding: 60 → 65 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

29% less capital invested

Capital invested by funds: $102M → $72.3M (-$29.7M)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
24
Reduced
16
Closed
10
Calls
$121K
Puts
–
Net Calls
+$121K
Net Calls Change
+$121K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$964K
2
BI
BVF Inc
California
+$849K
3
OAM
Oxford Asset Management
United Kingdom
+$725K
4
WMSA
Weiss Multi-Strategy Advisers
New York
+$706K
5
Wells Fargo
Wells Fargo
California
+$688K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$1.47M
2
EAM
Eventide Asset Management
Massachusetts
-$1.36M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1M
4
NC
Nexthera Capital
New York
-$752K
5
SFM
Sphera Funds Management
Israel
-$706K

IMDZ Hedge Fund Activity: Q4 2016 in Review

65 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q4 2016, worth a combined $72.3M — down 29% from $102M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IMDZ positions and 10 closed out — a net gain of 5 holders — while 24 added to existing stakes and 16 trimmed.

The largest buyer was Millennium Management, adding an estimated $964K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.47M.

  • 65 institutional investors held Immune Design Corp. (IMDZ) as of Q4 2016, up from 60 in Q3 2016.
  • Funds reported $72.3M of Immune Design Corp. stock for Q4 2016, down 29% quarter-over-quarter.
  • 15 funds opened new Immune Design Corp. positions in Q4 2016 and 10 closed out, a net change of +5 holders.
  • The largest Immune Design Corp. buyer in Q4 2016 was Millennium Management, an estimated $964K added.
  • The largest Immune Design Corp. seller in Q4 2016 was BlackRock Fund Advisors, an estimated $1.47M sold.

Based on aggregated 13F filings for Q4 2016.